As of March 2024 Precigen has a market cap of $0.36 Billion. This makes Precigen the world's 6373th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.36 B | 8.21% |
2023 | $0.33 B | 5.42% |
2022 | $0.31 B | -58.75% |
2021 | $0.76 B | -59.47% |
2020 | $1.89 B | 111.51% |
2019 | $0.89 B | -14.5% |
2018 | $1.04 B | -25.49% |
2017 | $1.40 B | -51.25% |
2016 | $2.88 B | -18.08% |
2015 | $3.51 B | 27.05% |
2014 | $2.76 B | 19.85% |
2013 | $2.30 B |
On Mar 27th, 2024 the market cap of Precigen was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Organovo ONVO | $10.34 M | -97.13% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | $0.38 B | 5.31% | ๐ฌ๐ง UK |
Novavax NVAX | $0.66 B | 85.35% | ๐บ๐ธ USA |
Novocure
NVCR | $1.67 B | 363.76% | Jersey |